Latest Articles

Publication Date
Pharmacologic Interventions for Endometriosis-Related Pain: A Systematic Review and Meta-analysis.

(Abstracted from Obstet Gynecol 2025;146(2):e23-e35) An estimated 10% to 15% of women who are of reproductive age are affected by endometriosis, defined as abnormal growth of endometrium-like tissue outside of …

Published: Nov. 7, 2025, midnight
Presacral Clear Cell Carcinoma of Müllerian Origin 20 Years After Hysterectomy and Bilateral Salpingo-Oophorectomy: A Case Report and Literature Review.

Primary presacral clear cell carcinoma (CCC) of Müllerian origin is extremely rare. Malignant transformation of endometriosis is a known phenomenon, though typically involving the ovaries or pelvic peritoneum. Retroperitoneal presentation, …

Published: Nov. 7, 2025, midnight
Spontaneous Pneumothorax: A Review of Underlying Etiologies and Diagnostic Imaging Modalities.

This review focuses on the diverse etiologies of secondary spontaneous pneumothorax (SSP) and the crucial role of imaging in their diagnosis. Unlike primary spontaneous pneumothorax (PSP), which is typically due …

Published: Nov. 7, 2025, midnight
Safety of 48 months of elagolix with add-back therapy for endometriosis-associated pain.

Elagolix (ELA) 200 mg twice daily is an oral treatment approved for moderate-to-severe endometriosis-associated pain. However, the clinical use of ELA is limited by potential hypoestrogenic effects, including the loss …

Published: Nov. 7, 2025, midnight
Will Ashland Inc. stock outperform value stocks - M&A Rumor & Verified Short-Term Trading Plans - fcp.pa.gov.br

Will Ashland Inc. stock outperform value stocks - M&A Rumor & Verified Short-Term Trading Plans fcp.pa.gov.br

Published: Nov. 6, 2025, 7:45 a.m.
Hormonal contraceptives linked to higher breast cancer risk, study finds - The Eastleigh Voice

Hormonal contraceptives linked to higher breast cancer risk, study finds The Eastleigh Voice

Published: Nov. 6, 2025, 3:53 a.m.
Associations of PFAS exposure with obstetric and birth outcomes in the Japan Environment and Children's Study (JECS): Is maternal endometriosis an effect modifier?

Per- and polyfluoroalkyl substances (PFAS) are reportedly associated with adverse obstetric outcomes, including premature labor and gestational diabetes. We aimed to evaluate associations of maternal PFAS exposure with obstetric and …

Published: Nov. 6, 2025, midnight
Sonographic and Clinical Progression of Adenomyosis and Coexisting Endometriosis: Long-Term Insights and Management Perspectives.

Objectives: To evaluate the impact of hormonal therapy on the evolution of painful symptoms in premenopausal women with adenomyosis, with or without concomitant endometriosis, over an 18-month follow-up period. This …

Published: Nov. 6, 2025, midnight
Merck secures $700 million funding from Blackstone to develop cancer therapy - ETPharma.com

Merck secures $700 million funding from Blackstone to develop cancer therapy ETPharma.com

Published: Nov. 5, 2025, 12:32 p.m.
Merck secures $700 million funding from Blackstone to develop cancer therapy - ET Pharma

Merck secures $700 million funding from Blackstone to develop cancer therapy ET Pharma

Published: Nov. 5, 2025, 12:32 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!